Profarma Distribuidora de Produtos Farmaceuticos SA ( ($BR:PFRM3) ) has shared an update. Profarma Distribuidora de Produtos Farmacêuticos S.A. announced that controlling shareholders BMK Participações S.A. and Sammy Birmarcker received
Established in 1961 and headquartered in Rio de Janeiro, Brazil, Profarma Distribuidora de Produtos Farmacêuticos S.A. is a prominent player in the Brazilian healthcare market, focusing on both the wholesale and retail sales of pharmaceutical and hospital supplies. The company's operations are divided into distinct Distribution and Retail segments. Its comprehensive product offerings include a vast array of pharmaceuticals, such as brand-name drugs, generic alternatives, and over-the-counter medications. Profarma also supplies essential hospital products, including injectable and infusion therapies for specialized medical areas like oncology, endocrinology, rheumatology, infectology, and hematology. Furthermore, it provides specific treatments such as vaccines for conditions like influenza, HPV, meningitis, hepatitis, chickenpox, and dengue, alongside specialized medicines for rare and complex diseases. Beyond pharmaceuticals, the company distributes a wide selection of personal care, beauty, and cosmetic items. This category encompasses shampoos, conditioners, treatment creams, hair dyes, baby products like diapers, soaps, deodorants, oral care essentials, sunscreens, men's grooming products, cosmetics, makeup, and skincare. Profarma also features proprietary lines under the Nº21, GOnutri, and Bem Básico brands, offering exclusive hygiene and beauty products, vitamins, and workshop items. Complementing these, convenience goods such as food products, blood pressure monitors, and scales are also available. The company extends its services to include promotional and logistical support, implementation of marketing campaigns, product recall management, development of bespoke solutions for laboratories, and oversight of clinical procedures.
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |
